A Landscape of Therapeutic Cooperativity in KRAS Mutant Cancers Reveals Principles for Controlling Tumor EvolutionGrace R. Anderson, Kris C. Wood, Peter Winter et al.|Cell Reports|2017Cited by 86
The Pan-RAF–MEK Nondegrading Molecular Glue NST-628 Is a Potent and Brain-Penetrant Inhibitor of the RAS–MAPK Pathway with Activity across Diverse RAS- and RAF-Driven CancersMeagan B. Ryan, Margit Hagel, Bradley Quade et al.|Cancer Discovery|2024Cited by 43
Abstract A086: NST-628 is a novel molecular glue that inhibits signaling and pathway reactivation in oncogenic RAS-MAPK cancersBradley Quade, Michael Hale, Meagan B. Ryan et al.|Molecular Cancer Therapeutics|2023Cited by 1
Data from The Pan-RAF–MEK Nondegrading Molecular Glue NST-628 Is a Potent and Brain-Penetrant Inhibitor of the RAS–MAPK Pathway with Activity across Diverse RAS- and RAF-Driven CancersMeagan B. Ryan, Margit Hagel, Bradley Quade et al.|Unknown|2024Cited by 1
Supplementary Methods from The Pan-RAF–MEK Nondegrading Molecular Glue NST-628 Is a Potent and Brain-Penetrant Inhibitor of the RAS–MAPK Pathway with Activity across Diverse RAS- and RAF-Driven CancersMeagan B. Ryan, Margit Hagel, Bradley Quade et al.|Unknown|2024Cited by 1